Press releases about Cesca Therapeutics
From PR Newswire
Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
October 24, 2019
From PR Newswire
Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Services
October 22, 2019
From PR Newswire
Cesca Therapeutics To Present At The 2019 Bio Investor Forum
October 14, 2019
From PR Newswire
From PR Newswire
ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices
September 25, 2019
From PR Newswire
Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products
September 09, 2019
From PR Newswire
Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment Conference
September 03, 2019
From PR Newswire
Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate Update
August 13, 2019
From PR Newswire
Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On August 13
August 06, 2019
From PR Newswire
From PR Newswire
Cesca Therapeutics Regains Nasdaq Listing Compliance
June 26, 2019
From PR Newswire
Cordlife to Use the ThermoGenesis AXP® II System for Rapid Processing of Cord Blood Units in India
June 25, 2019
From PR Newswire
More Health Canada Approval with Rise of Cannabis/OTC Markets ($INNV) ($NEPT) ($WDDMF) ( $KOOL)
June 20, 2019
From Issuewire
ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood Processing
June 18, 2019
From PR Newswire
ThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine Symposium
June 05, 2019
From PR Newswire
From PR Newswire
Cesca Therapeutics Announces First Quarter 2019 Financial Results And Provides Corporate Update
May 14, 2019
From PR Newswire
From PR Newswire
ThermoGenesis Releases its Enhanced X-MINI® CD3 Selection Kit for the Research Market
April 17, 2019
From PR Newswire
From PR Newswire
Cesca Therapeutics Announces Fiscal 2018 Year End Financial Results And Provides Corporate Update
March 25, 2019
From PR Newswire
Cesca Therapeutics To Announce Financial Results For The Fourth Quarter Ended December 31, 2018 and Host Conference Call On March 25
March 20, 2019
From PR Newswire
ThermoGenesis Receives Health Canada Approval of its PXP System for Automated Processing of Bone Marrow Cells
February 25, 2019
From PR Newswire
ThermoGenesis Corp X-Series Control Module and Docking Stations Cleared for Labelling by TÜV Rheinland with the cTUVus Electrical Safety Mark
February 11, 2019
From PR Newswire
Cesca Therapeutics to Present at the BIO CEO & Investor Conference
February 06, 2019
From PR Newswire
From PR Newswire
ThermoGenesis Corp® Completes Construction and Qualification of In-House Clean Room for Assembly of All X-Series™ Cell Processing Disposables
January 21, 2019
From PR Newswire
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.